Skip to main content
. Author manuscript; available in PMC: 2018 Jun 20.
Published in final edited form as: Circulation. 2017 Apr 27;135(25):2494–2504. doi: 10.1161/CIRCULATIONAHA.116.025678

Figure 2.

Figure 2

Associations for baseline or on-statin HDL-related biomarkers and incident events.

Odds ratios for baseline (A) and on-statin (B) HDL-related biomarkers are reported per standard deviation (SD) increment based on a conditional logistic regression analysis adjusted for matched design as well as for the following risk factors and biomarkers: age, race, treatment group, smoking status, systolic blood pressure, body-mass index, fasting glucose, LDL cholesterol level, log-transformed triglycerides, and family history of premature coronary artery disease. Models analyzing on-statin biomarkers incorporated on-treatment values for LDL cholesterol and log-transformed triglycerides.